Clinical trial managers recruit patients through two primary methods: pull and push. Pull involves physicians who are principal investigators referring their own patients. Push involves encouraging patients to find a particular investigator through advertisements in various media outlets like television, social media, and radio. Issues with patient recruitment and enrollment are the main causes of missed clinical trial timelines, which can cost companies millions of dollars in lost sales per day.

1. Patients recruitment into
clinical trials
Advertisements and incentive payments
A student seminar - Bshr Nammouz - 3’rd year medical school - SSST

3. Two primary ways clinical trial managers can find patients to fill
their trials:
1. Pull:
A patient can be pulled into clinical trials by way of their
physician who happens to be a principal investigator for
a clinical study.
You trust
me, right?

4. 2. Push:
Patients are encouraged to find a particular
investigator or site, typically one they may have
little or no previous contact with. Pushing patients
towards clinical trials may be done through media
outlets such as television, social media, billboards,
radio advertisements, email targeting, etc.
Welcome
to our
clinical trial

5. - Issues with patient recruitment and enrollment are the primary causes for missing
clinical trial timelines.
- Each day a company goes beyond the planned deadline for a clinical trial, that
company could be losing as much as $600,000 in foregone sales of smaller
products and as much as $8 million on blockbuster drugs.

6. Normal
marketing

7. Medical trials
marketing

8. Example of a company:

11. Example of another company:
http://www.ppdi.com/Services/Clinical-Development/Site-Intelligence-Activation/Pati
ent-Recruitment

12. About the two companies:
WCCT: WCCT is a multi site, full-service
pharmaceutical contract research organization
(CRO) of outsourced early drug development and
late phase CRO services to the pharmaceutical,
biotechnology and medical device industries. We
are the specialized global drug development
professionals who offer an innovative, agile and
collaborative approach to every program we
deliver.
Acurian: Founded in 1998, Acurian, a subsidiary of
PPD, is a leading full-service provider of patient
enrollment and retention solutions for the life
sciences industry. The company increases the
enrollment performance of investigator sites
worldwide by identifying, contacting, pre-screening
and referring people who live in the local
community but are unknown to a research site. As
a result, trial sponsors complete enrollment
without incurring the unexpected expense of
adding sites or time.

13. Thanks for listening